Activist 13D/13G Filings - Kyverna Therapeutics Inc. (KYTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-10-10
12:36 pm
Purchase
13GKyverna Therapeutics Inc.
KYTX
JPMORGAN CHASE & CO
JPM
2,380,021
5.500%
2,380,021increase
(New Position)
View
2024-05-03
5:57 pm
Purchase
13DKyverna Therapeutics Inc.
KYTX
Vida Ventures LLC4,777,060
11.100%
4,777,060increase
(New Position)
View
2024-02-22
4:29 pm
Purchase
13GKyverna Therapeutics Inc.
KYTX
Northpond Ventures III LP3,255,426
7.600%
3,255,426increase
(New Position)
View
2024-02-20
4:31 pm
Purchase
13GKyverna Therapeutics Inc.
KYTX
GILEAD SCIENCES INC.
GILD
4,126,119
9.600%
4,126,119increase
(New Position)
View
2024-02-14
5:20 pm
Purchase
13GKyverna Therapeutics Inc.
KYTX
Bain Capital Life Sciences Opportunities III LP3,163,868
7.400%
3,163,868increase
(New Position)
View